Top Section/Ad
Top Section/Ad
Most recent
M&A could be much needed shot in the arm but dollars expected to dominate
Deal includes $1bn 3.75 year term loan
The German pharmaceutical wholesaler was upgraded to BBB- by S&P last month
US drug company Eli Lilly jolted the dollar market awake on Wednesday with an eight-part jumbo trade to fund two recent acquisitions
More articles/Ad
More articles/Ad
More articles
-
Galderma will provide the European IPO market with another important data point when it begins trading on Friday -
The final size of the base deal will be Sfr2bn after the IPO was priced at the top of the range
-
The biggest IPO of the year so far in Europe is multiple times covered, according to sources
-
KBRA expects to upgrade deal if merger with Orangetheory goes through
-
US drug maker's stake in Haleon set to fall to 24%
-
Risk appetite is back and more deals coming, though one bad IPO would damage confidence in the recovery
